Dorsal root ganglion (DRG) stimulation is an advanced, minimally invasive neuromodulation therapy used to help manage chronic nerve pain that has not responded to more conservative treatments. It works by delivering mild electrical pulses to a small cluster of nerve cells called the dorsal root ganglion, which plays a key role in how the body processes and transmits pain signals from a specific area, such as the foot, groin, or lower leg. Unlike some other neurostimulation options, DRG stimulation targets pain in a specific region rather than a broad area of the body. Because it involves an implanted device, candidacy always starts with an individual evaluation. At Center for Spine & Pain Medicine (CSPM), DRG stimulation is one of several advanced options available for patients with chronic, focal nerve pain.
Dorsal Root Ganglion Stimulation
What Is Dorsal Root Ganglion Stimulation?
Dorsal root ganglion stimulation, often called DRG-S, is a neuromodulation therapy that uses a small implanted device to deliver mild electrical pulses to the dorsal root ganglion, a cluster of sensory nerve cell bodies along the spine, to help reduce chronic nerve pain in a specific body region.
The dorsal root ganglion sits just outside the spinal canal at each spinal level and acts as a relay station for pain signals traveling from a nerve to the spinal cord and brain. By placing a thin lead near the targeted ganglion and delivering low-level electrical stimulation, DRG-S is designed to interrupt or modify pain signals before they reach the brain. This approach is often considered when pain is localized to a specific area, such as the foot, groin, knee, or lower leg, rather than being widespread across the body.
How Does Dorsal Root Ganglion Stimulation Work?
Dorsal root ganglion stimulation works by placing one or more thin leads near the targeted dorsal root ganglion and using a small implanted device to send mild electrical pulses that help modify how pain signals are processed before they travel further into the nervous system.
The system includes leads placed near the ganglion and a pulse generator implanted under the skin, typically in the upper buttock or abdomen. The device can often be programmed and adjusted for an individual's specific pain pattern. Because each dorsal root ganglion corresponds to a specific dermatome, or region of skin and underlying tissue, the therapy can be targeted to the area where pain is concentrated. Patients typically use an external device to turn stimulation on or off and to make approved adjustments within a range set by their physician.
What Conditions May Dorsal Root Ganglion Stimulation Help Treat?
Dorsal root ganglion stimulation may help manage chronic, focal nerve pain conditions, including complex regional pain syndrome (CRPS) and causalgia affecting the lower limbs, and it has also been studied for other focal neuropathic pain conditions.
A large randomized clinical trial found that DRG stimulation was associated with a significantly higher rate of treatment success for CRPS and causalgia of the lower limbs compared with traditional spinal cord stimulation, at both 3 and 12 months of follow-up. Based largely on this research, DRG-S received FDA approval for CRPS of the lower extremities. Some patients with other focal nerve pain conditions, including certain cases of chronic post-surgical nerve pain, may also be evaluated for DRG-S, though the supporting evidence for conditions outside CRPS and causalgia is more limited. A physician determines whether a specific condition may be appropriate for this therapy. For a broader look at chronic pain conditions CSPM evaluates, visit CSPM's conditions page.
Who May Be a Candidate for Dorsal Root Ganglion Stimulation?
A person may be a candidate for DRG stimulation if they have chronic, focal nerve pain, such as CRPS or causalgia of the lower limb, that has not responded adequately to at least two different types of pain medication and other conservative treatments, though a physician must confirm candidacy through individual evaluation.
Physicians typically look for pain that has been present for an extended period, generally at least six months, is concentrated in a specific region rather than widespread, and has not improved with prior treatment attempts. A psychological evaluation is often part of the process to help confirm that a patient is an appropriate candidate for an implanted device. Imaging, medical history, and a physical exam are also reviewed. CSPM providers who evaluate candidates are listed on CSPM's provider directory.
Who May Not Be a Candidate for Dorsal Root Ganglion Stimulation?
Certain patients may not be appropriate candidates, including those with an active infection, an uncontrolled bleeding disorder, an inability to operate the required device, or significant untreated psychological conditions that could affect the safety or success of an implanted device. This is not a complete list, and candidacy should always be confirmed directly with a physician.
What Happens Before the Procedure?
Before moving forward with DRG stimulation, patients typically undergo a thorough evaluation that may include a review of medical history, prior treatments, imaging, and in many cases a psychological assessment. The physician will discuss goals, expectations, and the two-step process involving a temporary trial followed by possible permanent implantation, and will review insurance authorization requirements. Specific preparation instructions, including any medication adjustments, should be confirmed directly with CSPM based on the individual treatment plan.
What Happens During the Trial Procedure?
DRG stimulation typically begins with a temporary trial period in which thin leads are placed near the target dorsal root ganglion using image guidance, connected to an external trial stimulator worn outside the body, so the patient and physician can assess whether the therapy meaningfully reduces pain before deciding on a permanent implant.
What Happens During the Permanent Implant Procedure?
If the trial is successful, the permanent implant procedure involves placing the leads near the targeted dorsal root ganglion and implanting a small pulse generator under the skin, typically performed with the patient sedated and imaging used to guide lead placement.
The implant procedure is generally more involved than the trial, since it includes securing the leads in place and creating a small pocket under the skin for the pulse generator. Depending on the number of leads needed, procedure time can vary. Patients are typically monitored afterward before being discharged.
Does Dorsal Root Ganglion Stimulation Hurt?
Most patients experience some discomfort from the local anesthetic and needle or incision sites rather than significant pain, though individual sensitivity varies and the permanent implant procedure may involve more soreness than the trial.
How Long Does the Procedure Take?
Procedure length can vary based on whether it is the trial phase or the permanent implant, and on the number of leads placed. Patients should ask CSPM directly for an expected appointment duration for each stage of the process.
How Long Is Recovery After Dorsal Root Ganglion Stimulation?
Recovery from the trial phase is typically brief, while recovery from the permanent implant procedure often involves a short period of activity restriction while the incision site heals, though timelines vary by patient.
During the trial, most patients can continue with light daily activities while wearing the external stimulator, with some precautions around bending, twisting, or getting the device wet. After a permanent implant, patients are often advised to limit strenuous activity, bending, and twisting for a period of time while the pocket site heals. Follow-up visits are typically scheduled to assess healing and adjust programming.
When Might a Patient Notice Results?
Because DRG stimulation uses a trial period before permanent implantation, many patients and physicians look for a noticeable reduction in pain within the first several days of the trial, as this response often helps determine whether to proceed with a permanent device. After permanent implantation, results are generally assessed on an ongoing basis as programming is adjusted.
How Long Might the Results Last?
In a large randomized trial, meaningful pain relief with DRG stimulation was reported to persist through 12 months of follow-up for the majority of patients who proceeded with a permanent implant, though outcomes vary by individual and long-term durability continues to be studied as more patients are followed over time. These findings describe outcomes across groups of study participants and do not predict how long relief will last for any one patient.
How Much Does Dorsal Root Ganglion Stimulation Cost?
Cost varies significantly based on individual insurance coverage, whether the patient proceeds beyond the trial phase to a permanent implant, and other individual factors, so an accurate estimate requires reviewing benefits directly with CSPM's billing team.
Because this therapy involves an implanted device, costs can include the trial procedure, the device itself, the implant procedure, facility fees, and follow-up programming visits. Patients can review general billing information on CSPM's financial policy page and should confirm specific costs before beginning the trial process.
Does Insurance Cover Dorsal Root Ganglion Stimulation?
Coverage varies by insurance plan and is generally tied to documented medical necessity, prior treatment failures, and, for many plans, a successful trial period, so patients should confirm their specific benefits rather than assume coverage.
Many insurers require documentation that conservative treatments and, in some cases, other interventions have already been tried without adequate relief. A successful trial period is typically required by insurers before authorizing the permanent implant. Patients can find general billing information on CSPM's financial policy page.
What Is the Success Rate of Dorsal Root Ganglion Stimulation?
In the largest randomized trial to date, comparing DRG stimulation with traditional spinal cord stimulation in patients with CRPS or causalgia of the lower limbs, 81.2% of DRG stimulation patients achieved at least 50% pain relief and met the study's treatment success criteria at 3 months, compared with 55.7% of patients using traditional spinal cord stimulation. At 12 months, 74.2% of DRG stimulation patients maintained treatment success, compared with 53.0% of those using traditional stimulation. DRG stimulation patients in this trial also reported less variation in sensation with changes in body position and less stimulation felt outside the painful area, suggesting more targeted therapy.
What Are the Risks and Side Effects?
As with any procedure involving an implanted device, there are possible risks and side effects, and patients should discuss these in detail with their physician before proceeding.
In the same large randomized trial, serious adverse events occurred in 10.5% of DRG stimulation patients compared with 14.5% of traditional stimulation patients, a difference that was not statistically significant, and no subjects experienced a stimulation-related neurological deficit. Reported risks and side effects can include pain or soreness at the incision or device-pocket site, lead migration, infection, and issues related to the device itself, such as uncomfortable stimulation sensations. Any signs of infection, unexpected pain, or changes in device function should be reported promptly to the treating physician.
What Are the Alternatives to Dorsal Root Ganglion Stimulation?
Alternatives may include continued medication management, physical therapy, other types of nerve blocks or injections, traditional spinal cord stimulation, or, in select cases, further surgical evaluation, and no single option is automatically the right choice for every patient.
Depending on the individual case and the specific pain condition, a physician may also discuss more targeted interventions such as medial branch blocks for facet-related pain, or traditional spinal cord stimulation for patients with broader or less clearly localized pain patterns.
How Does Dorsal Root Ganglion Stimulation Compare With Traditional Spinal Cord Stimulation?
| Feature | Dorsal root ganglion stimulation | Traditional spinal cord stimulation |
|---|---|---|
| Typical target | Focal, dermatome-specific pain (e.g., foot, groin, lower leg) | Broader regional pain patterns |
| Lead placement | Near the dorsal root ganglion at the targeted spinal level(s) | Dorsal epidural space, typically at a higher spinal level |
| FDA-approved indication | CRPS and causalgia of the lower extremities | Multiple chronic pain conditions, including failed back surgery syndrome and CRPS |
| Stimulation specificity | Designed for more focused, targeted sensation | Sensation may extend beyond the painful area |
| Trial-to-implant process | Temporary trial period before permanent implant decision | Temporary trial period before permanent implant decision |
| Reported treatment success (published trial data) | 81.2% at 3 months; 74.2% at 12 months | 55.7% at 3 months; 53.0% at 12 months |
This table reflects findings from a specific published trial in patients with lower-limb CRPS or causalgia and provides only a general comparison. It does not apply to every pain condition or patient. A physician determines which option, if any, fits a specific patient's diagnosis and treatment history.
When Should Someone Discuss Dorsal Root Ganglion Stimulation With a Pain Specialist?
Someone with chronic, focal nerve pain that has not improved with medication and other conservative treatments may want to ask a pain specialist whether DRG stimulation should be considered. A pain specialist can review the pain pattern, prior treatments, and overall health to help determine whether DRG stimulation, another type of neurostimulation, or a different approach is the most reasonable next step. To Schedule a consultation with CSPM, visit the appointment page.
Frequently Asked Questions
Is dorsal root ganglion stimulation the same as spinal cord stimulation?
No, though they are related therapies. Traditional spinal cord stimulation places leads in the epidural space to modulate pain signals across a broader region, while DRG stimulation targets the dorsal root ganglion at a specific spinal level to treat more focal, localized pain. Some patients may be candidates for one, the other, or, in certain cases, may switch from one therapy to the other if their initial results are not satisfactory. A physician determines which approach best fits an individual's pain pattern.
Do I need surgery to try dorsal root ganglion stimulation?
The initial trial phase is a minimally invasive, reversible process using temporary leads and an external device, not a permanent surgical implant. Only if the trial shows meaningful pain relief does a patient move forward with the more involved permanent implant procedure. This two-step process allows patients and physicians to assess the therapy's effectiveness before committing to a permanent device.
What happens if the trial period does not help my pain?
If the trial does not provide meaningful pain relief, the temporary leads are removed, and no permanent device is implanted. A lack of response during the trial is useful information that can help guide further treatment decisions. The physician may then discuss other therapies, including alternative types of neurostimulation or different treatment approaches.
Can dorsal root ganglion stimulation be removed if it stops working or is no longer needed?
Yes, both the temporary trial leads and a permanent implanted system can generally be removed if needed, though removal of a permanent implant is a surgical procedure. Decisions about removal, replacement, or reprogramming are made individually with the treating physician based on the patient's response and overall goals.
Is dorsal root ganglion stimulation only used for complex regional pain syndrome?
The FDA-approved indication for DRG stimulation is CRPS and causalgia affecting the lower extremities, based on the strongest available clinical trial evidence. Some physicians may consider DRG stimulation for other focal neuropathic pain conditions based on individual evaluation, though the supporting evidence for other conditions is more limited.
Will I be able to feel the stimulation from the device?
Many patients do notice a sensation from the device, sometimes described as a mild tingling, though individual experiences vary, and some newer stimulation settings are designed to minimize it. Programming can often be adjusted to find a comfortable and effective setting for each patient.
Medical Review
Reviewed by Dr. Sadiq, MD.
Sources
- Dorsal root ganglion stimulation yielded higher treatment success rate for complex regional pain syndrome and causalgia at 3 and 12 months: a randomized comparative trial – Pain (Deer TR, et al.), 2017.
- Dorsal Root Ganglion Stimulation for Lower Extremity Neuropathic Pain Syndromes: An Evidence-Based Literature Review – Cureus / PMC, 2022.
- Continuous electrical stimulation of the dorsal root ganglion (DRG-S) as a salvage therapy in patients previously treated with spinal cord stimulation: systematic review and pooled analysis – PMC, 2025.